Published in Retina on March 01, 2008
Elevated vascular endothelial growth factor level in Coats' disease and possible therapeutic role of bevacizumab. Graefes Arch Clin Exp Ophthalmol (2010) 1.21
Pars plana vitrectomy for treatment of advanced Coats' disease--presentation of a modified surgical technique and long-term follow-up. Graefes Arch Clin Exp Ophthalmol (2013) 0.90
Advanced Coats' disease treated with intravitreal bevacizumab combined with laser vascular ablation. Clin Ophthalmol (2014) 0.87
Transscleral diode photocoagulation of large retinal and choroidal vascular lesions. PLoS One (2012) 0.80
Treatment of stage 3 Coats' disease by endolaser photocoagulation via a two-port pars plana nonvitrectomy approach. Graefes Arch Clin Exp Ophthalmol (2015) 0.80
Coats' Disease: Very Long-Term Outcome After Early Stage Conventional Treatment. Open Ophthalmol J (2016) 0.77
Risk of Tractional Retinal Detachment Following Intravitreal Bevacizumab Along with Subretinal Fluid Drainage and Cryotherapy for Stage 3B Coats' Disease. Middle East Afr J Ophthalmol (2016) 0.75
Evaluation of Follow-Up and Treatment Results in Coats' Disease. Turk J Ophthalmol (2016) 0.75
Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol (2003) 4.78
Exudative retinal detachment following photocoagulation in older premature infants for retinopathy of prematurity: description and management. Retina (2014) 3.20
Off-label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity. Retina (2008) 3.12
Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center. Retina (2011) 2.97
Retinopathy of prematurity in the time of bevacizumab: incorporating the BEAT-ROP results into clinical practice. Ophthalmology (2011) 2.38
Telemedical retinopathy of prematurity diagnosis: accuracy, reliability, and image quality. Arch Ophthalmol (2007) 2.22
Retained lens fragments after cataract surgery: outcomes of same-day versus later pars plana vitrectomy. Am J Ophthalmol (2013) 2.13
Initial outcomes following intravitreal ocriplasmin for treatment of symptomatic vitreomacular adhesion. Ophthalmic Surg Lasers Imaging Retina (2013) 1.98
Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy. Retina (2002) 1.86
Delayed- versus acute-onset endophthalmitis after cataract surgery. Am J Ophthalmol (2011) 1.83
Acute-onset endophthalmitis after clear corneal cataract surgery (1996-2005). Clinical features, causative organisms, and visual acuity outcomes. Ophthalmology (2007) 1.79
Clinical and pathologic characteristics of biopsy-proven iris melanoma: a multicenter international study. Arch Ophthalmol (2011) 1.78
Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema. Retina (2008) 1.75
Endophthalmitis caused by Mycobacterium chelonae: selection of antibiotics and outcomes of treatment. Arch Ophthalmol (2003) 1.44
Novel mutation in BEST1 associated with retinoschisis. JAMA Ophthalmol (2013) 1.42
Supraselective intra-arterial chemotherapy: evaluation of treatment-related complications in advanced retinoblastoma. Clin Ophthalmol (2011) 1.38
Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors. J Neurosurg (2011) 1.37
The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19. Ophthalmology (2002) 1.29
Endophthalmitis caused by Mycobacterium chelonae abscessus after intravitreal injection of triamcinolone. Arch Ophthalmol (2003) 1.26
Ciliary body medulloepithelioma: four cases associated with pleuropulmonary blastoma--a report from the International Pleuropulmonary Blastoma Registry. Br J Ophthalmol (2010) 1.25
Evaluation of a computer-based system for plus disease diagnosis in retinopathy of prematurity. Ophthalmology (2007) 1.21
Intraoperative OCT of a full-thickness macular hole before and after internal limiting membrane peeling. Ophthalmic Surg Lasers Imaging (2010) 1.19
Intravitreal injection analysis at the Bascom Palmer Eye Institute: evaluation of clinical indications for the treatment and incidence rates of endophthalmitis. Clin Ophthalmol (2010) 1.14
Targeting hypoxia, a novel treatment for advanced retinoblastoma. Invest Ophthalmol Vis Sci (2008) 1.12
Combined phacoemulsification and sutureless 23-gauge pars plana vitrectomy for complex vitreoretinal diseases. Br J Ophthalmol (2010) 1.12
Retinal tumor imaging and volume quantification in mouse model using spectral-domain optical coherence tomography. Opt Express (2009) 1.11
Outcomes of surgery for retinal detachment associated with proliferative vitreoretinopathy using perfluoro-n-octane: a multicenter study. Am J Ophthalmol (2003) 1.11
Current update on retinoblastoma. Int Ophthalmol Clin (2011) 1.10
Retinoblastoma tumor vessel maturation impacts efficacy of vessel targeting in the LH(BETA)T(AG) mouse model. Invest Ophthalmol Vis Sci (2007) 1.10
Comparison of intravitreal bevacizumab followed by ranibizumab for the treatment of neovascular age-related macular degeneration. Retina (2009) 1.09
Immediate postoperative use of a topical agent to prevent intraocular pressure elevation after pars plana vitrectomy with gas tamponade. Arch Ophthalmol (2004) 1.08
Bilateral choroidal effusions associated with dengue fever. Retina (2003) 1.08
Antiangiogenic activity of 2-deoxy-D-glucose. PLoS One (2010) 1.08
Blood vessel maturation in retinoblastoma tumors: spatial distribution of neovessels and mature vessels and its impact on ocular treatment. Invest Ophthalmol Vis Sci (2008) 1.08
Clinical features and outcomes of pars plana vitrectomy in patients with retained lens fragments. Ophthalmology (2003) 1.06
Spectral domain optical coherence tomography in a murine retinal detachment model. Exp Eye Res (2010) 1.06
Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation. Ophthalmology (2006) 1.05
One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusion. Retina (2006) 1.05
Visual and anatomic outcomes with or without surgery in persistent fetal vasculature. Ophthalmology (2010) 1.03
Telemedical diagnosis of retinopathy of prematurity: accuracy of expert versus non-expert graders. Br J Ophthalmol (2009) 1.03
Current Infectious Endophthalmitis Rates After Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Agents and Outcomes of Treatment. Ophthalmic Surg Lasers Imaging Retina (2015) 1.03
Laser flare photometry and complications of chronic uveitis in children. Am J Ophthalmol (2003) 1.02
Safety and efficacy of intravitreal bevacizumab (avastin) for the management of branch and hemiretinal vein occlusion. Retina (2009) 1.02
Outcomes of complex retinal detachment repair using 1000- vs 5000-centistoke silicone oil. Arch Ophthalmol (2005) 1.02
Outcomes and complications associated with giant retinal tear management using perfluoro-n-octane. Ophthalmology (2002) 1.02
Comparison of predictions made by the intraocular lens master and ultrasound biometry. Arch Ophthalmol (2008) 1.00
Plus disease in retinopathy of prematurity: quantitative analysis of vascular change. Am J Ophthalmol (2010) 1.00
Retinal detachment in eyes undergoing pars plana vitrectomy for removal of retained lens fragments. Ophthalmology (2003) 1.00
MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells. Cancer Res (2007) 0.98
Distinguishing torpedo maculopathy from similar lesions of the posterior segment. Ophthalmic Surg Lasers Imaging Retina (2014) 0.98
Endophthalmitis caused by staphylococcus epidermidis: in vitro antibiotic susceptibilities and clinical outcomes. Ophthalmic Surg Lasers Imaging (2007) 0.97
Clinicopathologic review of enucleated eyes after intra-arterial chemotherapy with melphalan for advanced retinoblastoma. Arch Ophthalmol (2010) 0.97
Long-term safety and efficacy of intravitreal bevacizumab (Avastin) for the management of central retinal vein occlusion. Retina (2008) 0.96
Anecortave acetate as single and adjuvant therapy in the treatment of retinal tumors of LH(BETA)T(AG) mice. Invest Ophthalmol Vis Sci (2006) 0.95
Retinoblastoma treatment burden and economic cost: impact of age at diagnosis and selection of primary therapy. Clin Ophthalmol (2012) 0.95
Increased hypoxia following vessel targeting in a murine model of retinoblastoma. Invest Ophthalmol Vis Sci (2009) 0.95
Quality of life after iodine 125 brachytherapy vs enucleation for choroidal melanoma: 5-year results from the Collaborative Ocular Melanoma Study: COMS QOLS Report No. 3. Arch Ophthalmol (2006) 0.93
Endophthalmitis caused by Bacillus species. Am J Ophthalmol (2008) 0.93
Comparison of retinoblastoma reduction for chemotherapy vs external beam radiotherapy. Arch Ophthalmol (2003) 0.93
Retinoblastoma. Curr Opin Ophthalmol (2013) 0.92
Intraoperative OCT of bilateral macular coloboma in a child with Down syndrome. J Pediatr Ophthalmol Strabismus (2011) 0.92
Mechanism of retinoblastoma tumor cell death after focal chemotherapy, radiation, and vascular targeting therapy in a mouse model. Invest Ophthalmol Vis Sci (2007) 0.92
Development of multiple subretinal hemorrhages during diode laser supplementation for retinopathy of prematurity. J Pediatr Ophthalmol Strabismus (2006) 0.92
Uveal melanoma presenting as acute angle-closure glaucoma: report of two cases. Am J Ophthalmol (2003) 0.92
Pars plana lensectomy and intraocular lens implantation in pediatric radiation-induced cataracts in retinoblastoma. Ophthalmology (2005) 0.91
Simultaneous presentation of retinopathy of prematurity and bilateral familial retinoblastoma in a premature infant. J Pediatr Ophthalmol Strabismus (2003) 0.91
Early onset endophthalmitis caused by Aspergillus species following cataract surgery. Am J Ophthalmol (2006) 0.90
Concomitant bilateral intravitreal anti-VEGF injections for the treatment of exudative age-related macular degeneration. Clin Ophthalmol (2010) 0.90
The Wnt signaling pathway has tumor suppressor properties in retinoblastoma. Biochem Biophys Res Commun (2006) 0.89
Heterogeneous tumor vasculature in retinoblastoma: implications for vessel targeting therapy. Retina (2008) 0.89
Gelatinase expression in retinoblastoma: modulation of LH(BETA)T(AG) retinal tumor development by anecortave acetate. Invest Ophthalmol Vis Sci (2010) 0.89
Intraoperative spectral-domain optical coherence tomography in coats' disease. Ophthalmic Surg Lasers Imaging (2012) 0.88
Combination therapy with triamcinolone acetonide and bevacizumab for the treatment of severe radiation maculopathy in patients with posterior uveal melanoma. Clin Ophthalmol (2013) 0.88
Pharmacokinetics of systemic versus focal Carboplatin chemotherapy in the rabbit eye: possible implication in the treatment of retinoblastoma. Invest Ophthalmol Vis Sci (2004) 0.88
Ultra-high resolution spectral domain optical coherence tomography of traumatic maculopathy. Ophthalmic Surg Lasers Imaging (2009) 0.88
Clinical manifestations of optic pit maculopathy as demonstrated by spectral domain optical coherence tomography. Clin Ophthalmol (2013) 0.88
Early SD-OCT diagnosis followed by prompt treatment of radiation maculopathy using intravitreal bevacizumab maintains functional visual acuity. Clin Ophthalmol (2012) 0.88
Ocular hypertension after intravitreal triamcinolone with vitrectomy and phacoemulsification. Clin Ophthalmol (2012) 0.87
Loss of Foveal Cone Photoreceptor Outer Segments in Occult Macular Dystrophy. Ophthalmic Surg Lasers Imaging (2010) 0.87
Salvage external beam radiotherapy of retinal capillary hemangiomas secondary to von Hippel-Lindau disease: visual and anatomic outcomes. Ophthalmology (2004) 0.87
Combretastatin A-4 prodrug in the treatment of a murine model of retinoblastoma. Invest Ophthalmol Vis Sci (2005) 0.86
Radioactive plaque therapy. Int Ophthalmol Clin (2006) 0.86
Intraocular infections in the neonatal intensive care unit. Clin Ophthalmol (2012) 0.86
Paclitaxel in the treatment of retinal tumors of LH beta-Tag murine transgenic model of retinoblastoma. Invest Ophthalmol Vis Sci (2007) 0.86
Bevacizumab for the treatment of pediatric retinal and choroidal diseases. Ophthalmic Surg Lasers Imaging (2010) 0.85